Milad Nazarzadeh Selected Research

Milad Nazarzadeh Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2019
4	Heart Failure 01/2023 - 01/2019
3	Aortic Valve Stenosis (Aortic Stenosis) 11/2023 - 01/2020
2	Neoplasms (Cancer) 06/2022 - 01/2021
2	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2020 - 10/2017
2	Hypertension (High Blood Pressure) 05/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
1	Chronic Disease (Chronic Diseases) 02/2024
1	Inflammation (Inflammations) 11/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Peripheral Arterial Disease 01/2023
1	Stroke (Strokes) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Drug Resistant Epilepsy 04/2022
1	Epilepsy (Aura) 04/2022
1	Myocardial Infarction 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Atrial Fibrillation 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Multiple Sclerosis 10/2020
1	Meningitis 10/2019
1	Diabetes Mellitus 01/2019
1	Labor Pain 09/2018
1	Pterygium 01/2018
1	Latent Tuberculosis 01/2016
1	Substance-Related Disorders (Drug Abuse) 01/2014
1	Pain (Aches) 01/2014

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 10/2020 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2019
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2021 - 01/2021
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 01/2021
2	Insulin (Novolin)FDA Link 06/2022 - 10/2020
2	Angiotensin Receptor AntagonistsIBA 11/2021 - 01/2021
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 11/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 05/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2023
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 11/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2023
1	canakinumab FDA Link 11/2023
1	Tubulin ModulatorsIBA 11/2023
1	Immunomodulating AgentsIBA 11/2023
1	tocilizumab (atlizumab)FDA Link 11/2023
1	Colchicine FDA LinkGeneric 11/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 04/2022
1	Cytochrome P-450 CYP3AIBA 04/2022
1	ThiazidesIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2020
1	LDL CholesterolIBA 10/2020
1	HDL LipoproteinsIBA 10/2020
1	oxidized low density lipoproteinIBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	HDL CholesterolIBA 10/2020
1	CopperIBA 10/2020
1	Proline (L-Proline)FDA Link 05/2020
1	Conjugate VaccinesIBA 10/2019
1	Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)IBA 10/2019
1	VaccinesIBA 10/2019
1	PentavacIBA 10/2019
1	Combined VaccinesIBA 10/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	EntonoxIBA 09/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	cysteinylcysteineIBA 01/2018
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 10/2017
1	Nitrogen DioxideIBA 01/2016
1	Tuberculin (PPD)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2014
1	Tramadol (K315)FDA LinkGeneric 01/2014
1	OpiumIBA 01/2014
1	Morphine (MS Contin)FDA LinkGeneric 01/2014
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2014
1	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2014
1	Analgesics (Analgesic Drugs)IBA 01/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2023 - 04/2022
2	Therapeutics 01/2022 - 10/2020
1	Polypharmacy 02/2024
1	Immunomodulation 11/2023
1	Secondary Prevention 01/2022
1	Catheters 10/2020
1	Continuity of Patient Care 01/2019
1	Drug Prescriptions 01/2019
1	Spinal Anesthesia 09/2018
1	Spinal Injections 09/2018